71 Results for "

RCC

" in MedChemExpress (MCE) Product Catalog:
Products (71)

71 Results for "RCC" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-18728
CAS No.: 724741-75-7
Target:  

GLUT Autophagy

Research Areas:  

Cancer

STF-31 is a selective inhibitor of glucose transporter 1 (GLUT1), with an IC50 of 1 μM. STF-31 is also a NAMPT inhibitor. STF-31 inhibits glucose uptake in renal cell carcinoma (RCC) 4 cells .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-112780
CAS No.: 1394011-91-6
Purity:  99.92%
Target:  

MDM-2/p53 Apoptosis

Research Areas:  

Cancer

UC2288 is a potent and orally active p21 attenuator (relatively selective activity for p21), which is synthesized based Sorafenib (HY-10201). UC2288 potently inhibits cancer cell growth by inducing apoptosis. UC2288 has no inhibition of VEGFR2 and Raf kinases even at 10 μM .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-112467
CAS No.: 682745-40-0
Purity:  ≥99.0%
Synonyms: AV-951 hydrate; KRN951 hydrate
Target:  

VEGFR

Research Areas:  

Cancer

Tivozanib hydrate (AV-951 hydrate; KRN951 hydrate) is the hydrate form of Tivozanib (HY-10977). Tivozanib hydrate is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib hydrate exhibits antitumor efficacy .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-122615
CAS No.: 2136270-20-5
Purity:  99.56%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

SPOP-IN-6b is a speckle-type POZ protein (SPOP) inhibitor with an IC50 of 3.58 μM (patent CN 107141287, SPOP-B-88) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139782
CAS No.: 66680-03-3
Purity:  99.23%
Research Areas:  

Cancer

SKLB325 is a Jumonji domain-containing 6 (JMJD6) inhibitor with a binding affinity (KD) value of 0.755 μM, and the IC50 value of 0.7797 μM. SKLB325 exhibits antitumor effects on ovarian cancer in vivo and in vitro. SKLB325 induces apoptosis . SKLB325 exhibits remarkable antitumor efficacy in renal cell carcinoma (RCC) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-100746
CAS No.: 315702-99-9
Purity:  98.69%
Target:  

Autophagy

Research Areas:  

Cancer

STF-62247 is an autophagy inducer that selectively cytotoxic to VHL-deficient renal cell carcinoma (IC50 of 0.625 μM and 16 μM in RCC4 and RCC4/VHL cells, respectively) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2324
CAS No.: 11029-61-1
Gramicidin A is a peptide component of gramicidin, an antibiotic mixture originally isolated from B. brevis. Gramicidin A is a highly hydrophobic channel-forming ionophore that forms channels in model membranes that are permeable to monovalent cations. Gramicidin A induces degradation of hypoxia inducible factor 1 α (HIF-1α) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113165A
CAS No.: 6920-31-6
Purity:  ≥98.0%
Isobutyryl-L-carnitine chloride is a biomarker. Isobutyryl-L-carnitine chloride is a product of acyl-CoA dehydrogenases involved in fatty acid β-oxidation, and it buffers the mitochondrial acyl-CoA/CoA ratio, oxidizes branched-chain amino acids, and supports the endogenous antioxidant defense system. Isobutyryl-L-carnitine chloride is a plasma biomarker of hepatic OCT1 transporter inhibition. Isobutyryl-L-carnitine chloride is a urinary biomarker of renal cell carcinoma, and its levels are elevated one year after nephrectomy compared with before nephrectomy. Isobutyryl-L-carnitine chloride can be used in research on renal cell carcinoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113165
CAS No.: 25518-49-4
Isobutyryl-L-carnitine is a biomarker. Isobutyryl-L-carnitine is a product of acyl-CoA dehydrogenases involved in fatty acid β-oxidation, and it buffers the mitochondrial acyl-CoA/CoA ratio, oxidizes branched-chain amino acids, and supports the endogenous antioxidant defense system. Isobutyryl-L-carnitine is a plasma biomarker of hepatic OCT1 transporter inhibition. Isobutyryl-L-carnitine is a urinary biomarker of renal cell carcinoma, and its levels are elevated one year after nephrectomy compared with before nephrectomy. Isobutyryl-L-carnitine can be used in research on renal cell carcinoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72866
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CA12; CDNA FLJ20151 Fis, Clone COL08412; Carbonic Anhydrase 12; Carbonic Dehydratase; Carbonic Anhydrase XII; Carbonic Anhydrase; HsT18816; CA12 Protein; Tumor Antigen HOM-RCC-3.1.3; T18816; Carbonate Dehydratase XII; CAXII; CA-XII
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P99161
CAS No.: 2226775-26-2
Synonyms: BGB149

Target:  

TAM Receptor

Research Areas:  

Cancer

Tilvestamab (BGB149) is a humanized anti-AXL antibody that blocks AXL-mediated cell signaling. Tilvestamab significantly inhibits Gas6-induced AXL activation in 786-0-Luc RCC cells and inhibits downstream AKT phosphorylation. Tilvestamab can be used in cancer research, particularly in AXL overexpressing renal cell carcinomas .
loading...
    loading...
Cat. No.: HY-119425
CAS No.: 21416-67-1
Purity:  99.16%
Synonyms: ICRF 159
Target:  

Topoisomerase

Research Areas:  

Cancer

Razoxane (ICRF 159), a EDTA (HY-Y0682) derivative, is an orally active antiangiogenic topoisomerase II inhibitor. Razoxane has antineoplastic, antiangiogenic, and antimetastatic activities. Razoxanecan be used for the research of renal cell carcinoma (RCC), lung cancer and melanoma cancer .
loading...
    loading...
Cat. No.: HY-I0636
CAS No.: 608141-44-2
Synonyms: (R)-CC-10004
Research Areas:  

Inflammation/Immunology

(R)-Apremilast ((R)-CC-10004) is a enantiomer of Apremilast .
loading...
    loading...
Cat. No.: HY-P99027
CAS No.: 2137049-37-5
Synonyms: LAG525; IMP701; Hu5A8

Target:  

LAG-3

Research Areas:  

Cancer

Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules. Ieramilimab restores T-cell and NK-cell-mediated antileukemic immunity by reducing exhaustion and augmenting cytokine output and cytotoxicity. Ieramilimab increases the infiltration of cytotoxic T lymphocytes and reduces baseline densities of regulatory T cells (Tregs) and ADAM10-expressing tumor cells. Ieramilimab can be used for the study of various malignancies including melanoma, RCC, and advanced solid tumors .
loading...
    loading...
Cat. No.: HY-113165AS
Isobutyryl-L-carnitine-d3 chloride is the d3-labeled Isobutyryl-L-carnitine chloride (HY-113165A). Isobutyryl-L-carnitine chloride is a biomarker. Isobutyryl-L-carnitine chloride is a product of acyl-CoA dehydrogenases involved in fatty acid β-oxidation, and it buffers the mitochondrial acyl-CoA/CoA ratio, oxidizes branched-chain amino acids, and supports the endogenous antioxidant defense system. Isobutyryl-L-carnitine chloride is a plasma biomarker of hepatic OCT1 transporter inhibition. Isobutyryl-L-carnitine chloride is a urinary biomarker of renal cell carcinoma, and its levels are elevated one year after nephrectomy compared with before nephrectomy. Isobutyryl-L-carnitine chloride can be used in research on renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-15960
CAS No.: 1246203-32-6
Synonyms: VDC-597 free base
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

PWT-33597 (VDC-597) free base is a dual inhibitor of PI3Kα and mTOR, which can effectively block the signaling downstream of PI3K and mTOR. PWT-33597 free base is capable of inducing tumor cell apoptosis and inhibiting tumor growth. PWT-33597 free base has anti-tumor activity and can be used in the research of tumors such as renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-15960A
CAS No.: 1246203-36-0
Synonyms: VDC-597; SN33597
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

PWT-33597 (VDC-597) is a dual inhibitor of PI3Kα and mTOR, which can effectively block the signaling downstream of PI3K and mTOR. PWT-33597 is capable of inducing tumor cell apoptosis and inhibiting tumor growth. PWT-33597 has anti-tumor activity and can be used in the research of tumors such as renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-179392
Research Areas:  

Cancer

Sunitinib-platinum(IV) prodrug-1 (Complex A) is a Pt(IV) prodrug based on Cisplatin (HY-17394), and this design aims to enable Pt(IV) to be reduced to active Pt(II) under intracellular reducing conditions, while simultaneously releasing a derivative of Sunitinib (HY-10255A) with tyrosine kinase inhibitor (TKI) activity. Sunitinib-platinum(IV) prodrug-1 exhibits excellent cytotoxicity against renal cell carcinoma (RCC), causing DNA crosslinking and apoptosis. Sunitinib-platinum(IV) prodrug-1 inhibits the VEGFR/PDGFR signaling pathway, suppressing tumor growth and angiogenesis. Sunitinib-platinum(IV) prodrug-1 can be used for research on renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-I0636R
CAS No.: 608141-44-2
Synonyms: (R)-CC-10004 (Standard)
(R)-Apremilast (Standard) is the analytical standard of (R)-Apremilast. This product is intended for research and analytical applications. (R)-Apremilast ((R)-CC-10004) is a enantiomer of Apremilast .
loading...
    loading...
Cat. No.: HY-RS11783
Research Areas:  

Others

RCC1 Human Pre-designed siRNA Set A contains three designed siRNAs for RCC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...